JPS5726624A - Isolation of virus glycoprotein antigen and manufacture of vaccine thereby - Google Patents

Isolation of virus glycoprotein antigen and manufacture of vaccine thereby

Info

Publication number
JPS5726624A
JPS5726624A JP8504581A JP8504581A JPS5726624A JP S5726624 A JPS5726624 A JP S5726624A JP 8504581 A JP8504581 A JP 8504581A JP 8504581 A JP8504581 A JP 8504581A JP S5726624 A JPS5726624 A JP S5726624A
Authority
JP
Japan
Prior art keywords
vaccine
isolation
manufacture
virus glycoprotein
glycoprotein antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP8504581A
Other languages
English (en)
Inventor
Jiyan Rukururuku
Ruderu Jiyan Dou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo SA filed Critical Synthelabo SA
Publication of JPS5726624A publication Critical patent/JPS5726624A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
JP8504581A 1980-06-05 1981-06-04 Isolation of virus glycoprotein antigen and manufacture of vaccine thereby Pending JPS5726624A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8012522A FR2483779A1 (fr) 1980-06-05 1980-06-05 Procede pour isoler des antigenes glycoproteiques viraux et son application a la preparation de vaccins

Publications (1)

Publication Number Publication Date
JPS5726624A true JPS5726624A (en) 1982-02-12

Family

ID=9242745

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8504581A Pending JPS5726624A (en) 1980-06-05 1981-06-04 Isolation of virus glycoprotein antigen and manufacture of vaccine thereby

Country Status (19)

Country Link
US (1) US4344935A (ja)
EP (1) EP0041880B1 (ja)
JP (1) JPS5726624A (ja)
AR (1) AR228865A1 (ja)
AT (1) ATE3239T1 (ja)
AU (1) AU546088B2 (ja)
CA (1) CA1174598A (ja)
DE (1) DE3160264D1 (ja)
DK (1) DK228081A (ja)
ES (1) ES8203225A1 (ja)
FI (1) FI811685L (ja)
FR (1) FR2483779A1 (ja)
GR (1) GR74610B (ja)
IE (1) IE51226B1 (ja)
IL (1) IL62913A (ja)
NO (1) NO811873L (ja)
NZ (1) NZ197306A (ja)
PT (1) PT73032B (ja)
ZA (1) ZA813479B (ja)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01294629A (ja) * 1987-12-30 1989-11-28 New York Blood Center Inc ハロゲン化炭化水素により不安定生物混合物からプロセス化学薬品を抽出する方法
JPH02300268A (ja) * 1989-04-25 1990-12-12 Rheox Internatl Inc 液体沈降防止剤組成物

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4721675A (en) * 1982-02-01 1988-01-26 Abbott Laboratories Production of hepatitis A virus in vitro utilizing a persistently virus infected cell culture system
US4645666A (en) * 1982-06-08 1987-02-24 The Regents Of The University Of California Vaccine for bluetongue disease employing platinum compounds
GB8502096D0 (en) * 1985-01-28 1985-02-27 Medical Res Council Influenza vaccine
NZ224422A (en) 1987-05-05 1990-11-27 Molecular Eng Ass Composition adapted for intranasal immunisation against viral infection comprising a glycoprotein complexed with a lipid
US5741493A (en) * 1991-01-24 1998-04-21 Pasteur Merieux Serums Et Vaccins Vaccine composition against influenza, with synergic effects, containing influenza virus core as an additive
FR2671974A1 (fr) * 1991-01-24 1992-07-31 Pasteur Merieux Serums Vacc Composition vaccinale contre la grippe, a effet synergique, contenant comme additif du core de virus grippal.
US6780630B1 (en) * 1992-07-10 2004-08-24 Baylor College Of Medicine Parenteral immunization against rotavirus
FR2723740B1 (fr) * 1994-08-16 1996-11-08 Pasteur Merieux Serums Vacc Procede de preparation d'antigenes du virus grippal, antigenes obtenus et leurs applications
DE69629812T2 (de) 1995-06-14 2004-04-01 Baylor College Of Medicine, Houston Impfstoff gegen rotavirus infektionen enthaltend peptide des viralenterotoxines nsp4
US6673355B1 (en) 1995-06-14 2004-01-06 Baylor College Of Medicine Rotavirus enterotoxin NSP4 and methods of using same
DE19938767C2 (de) * 1999-08-16 2002-10-24 Tad Pharma Gmbh Spaltimpfstoffe

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE661402A (ja) 1964-03-20
US3847737A (en) * 1965-03-22 1974-11-12 A Kanarek Inactivation of myxoviruses and method of preparing a vaccine therefrom
US3629470A (en) * 1968-04-08 1971-12-21 Burroughs Wellcome Co Process for purification of animal rna viruses
BR6915288D0 (pt) * 1969-03-15 1973-02-08 Bayer Ag Processo para a purificacao de solucoes do virus da febre aftosa
US3989818A (en) * 1970-08-14 1976-11-02 South African Inventions Development Corporation Influenza virus vaccine
US3790552A (en) * 1972-03-16 1974-02-05 Us Health Method of removing hepatitis-associated antigen from a protein fraction using polyethylene glycol
US3962421A (en) * 1973-06-18 1976-06-08 American Home Products Corporation Method for the disruption of lipid-containing viruses
GB1486557A (en) 1973-10-18 1977-09-21 Flockhart & Co Process for the preparation of pyrogen-free sub-unit vaccine
US3951937A (en) * 1973-12-20 1976-04-20 The Community Blood Council Of Greater New York, Inc. Large scale purification of hepatitis type B antigen using polyethylene glycol
US4140762A (en) * 1974-01-14 1979-02-20 Sandoz Ltd. Influenza sub-unit vaccine
US4064232A (en) * 1974-01-14 1977-12-20 Sandoz Ltd. Process for isolating the immunogenic components of influenza viruses
AU507149B2 (en) 1975-01-16 1980-02-07 Mount Sinai School Of Medicine Of The City University Of New York, The Method of influenza immunization
FR2422720A2 (fr) 1977-04-26 1979-11-09 Elf Aquitaine Separation et purification de proteines par chromatographie
FI66020C (fi) * 1977-09-19 1984-08-10 Merck & Co Inc Foerfarande foer framstaellning av antigeniska immunogeniska subunits av hsv-1 och hsv-2
DE2750045A1 (de) * 1977-11-09 1979-05-10 Behringwerke Ag Verfahren zur entfernung von detergentien aus virusantigensuspensionen

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01294629A (ja) * 1987-12-30 1989-11-28 New York Blood Center Inc ハロゲン化炭化水素により不安定生物混合物からプロセス化学薬品を抽出する方法
JPH02300268A (ja) * 1989-04-25 1990-12-12 Rheox Internatl Inc 液体沈降防止剤組成物

Also Published As

Publication number Publication date
DE3160264D1 (en) 1983-06-16
PT73032B (fr) 1982-07-01
AR228865A1 (es) 1983-04-29
AU546088B2 (en) 1985-08-15
IE51226B1 (en) 1986-11-12
EP0041880A1 (fr) 1981-12-16
ES502549A0 (es) 1982-04-01
FR2483779A1 (fr) 1981-12-11
DK228081A (da) 1981-12-06
ZA813479B (en) 1982-06-30
US4344935A (en) 1982-08-17
FI811685L (fi) 1981-12-06
IL62913A0 (en) 1981-07-31
GR74610B (ja) 1984-06-29
CA1174598A (en) 1984-09-18
NO811873L (no) 1981-12-07
FR2483779B1 (ja) 1983-07-22
PT73032A (fr) 1981-06-01
NZ197306A (en) 1984-03-16
ES8203225A1 (es) 1982-04-01
EP0041880B1 (fr) 1983-05-11
ATE3239T1 (de) 1983-05-15
IE811168L (en) 1981-12-05
AU7117081A (en) 1981-12-10
IL62913A (en) 1984-08-31

Similar Documents

Publication Publication Date Title
IL68749A (en) Modified antigens,their preparation and vaccines containing them
JPS52114018A (en) Purification and isolation of hepatisis virus for producing vaccine
JPS55130920A (en) Liposome particle containing virus or bacteria antigen subunit
NZ193487A (en) Purification of human le form interferon proteins and antibodies thereto
ZA831854B (en) Small peptides with the specificity of foot and mouth disease viral antigens
DE3173713D1 (en) Formation of an immunosome exclusively made of viral antigens reconstituted on an artificial membrane
ZA826310B (en) Products displaying the antigenicity of hepatitis b virus e antigens and methods of producing those antigens
GR860987B (en) Antigens of the glycoprotein of the aids virus envelope specially of the glycoprotein precursors methods for obtaining these antigens means therefor and their applications
JPS5726624A (en) Isolation of virus glycoprotein antigen and manufacture of vaccine thereby
GB8304538D0 (en) Antibodies and antigens
DE3378959D1 (en) Methods for preparation of hepatitis b surface antigen free gamma globulins and products
NZ203190A (en) Vaccines of infections bronchitis virus
JPS57144227A (en) Manufacture of b type hepatitis vaccine
NZ195756A (en) Human cancer cell-associated nucleolar antigens and antibodies thereto;immunological detection of cancer
JPS5610119A (en) Manufacture of b type hepatitis infection preventive vaccine
JPS5244230A (en) Detection of hepatisis antigen and antibody and hepatisis vaccine
PH21427A (en) Malaria associated antigen and process of preparing thereof
IL60370A0 (en) Polyvalent virus vaccine and its preparation
HK79890A (en) Prophylactic and therapeutic use of muramyl peptides and their analogues against viral infections
IL81920A (en) Vaccines comprising an antigen and interferon-ypsilon and their preparation
JPS5589232A (en) Vaccines against reo virus disease and their manufacture
IE860983L (en) Antigens related to envelope glycoprotein of the virus of¹aids
IL59310A0 (en) Dtermination of malaria antigens and antibodies
GB8622883D0 (en) Expression of hepatitis b viral antigens
JPS55104215A (en) Parainfluenza virus vaccine and its manufacture